John Konstantopoulos

Co-Founder and CEO | Artificial Intelligence | Healthcare. Views are my own.

[John Konstantopoulos @joconstant]

https://t.co/Kvvy022R17

[John Konstantopoulos @joconstant]

Vulnerable plaque identification and its importance to patients.
#coronaryarterydisease #heartdisease #artificialintelligence https://t.co/zwI7PnGiB5

[John Konstantopoulos @joconstant]

Cardiac Imaging in 2040 - an additional opportunity for Cardiac CT is the ability to automate and provide information at the point of care Artrya Ltd #cardiacimaging #coronaryarterydisease #artificialintelligence #pointofcare The Imaging Wire @briancasey3 https://t.co/iTbMQA3YUP

[John Konstantopoulos @joconstant]

A new study out of Denmark shows that clinically silent coronary plaques was linked to a substantially elevated heart attack risk in middle-aged persons without known cardiovascular disease.

#coronaryarterydisease #plaques #hearta…https://t.co/qfNfKz3os3 https://t.co/3BE8Jxj8aF

[John Konstantopoulos @joconstant]

Momentum is growing for CCTA as a cardiac screening test.

“Researchers found that CCTA was remarkably effective in identifying individuals without symptoms who were more likely to experience heart attacks in years to come.”

#Yes…https://t.co/oDpf5O28WH https://t.co/9FcdxWeVBJ

[John Konstantopoulos @joconstant]

New artificial intelligence-driven software platforms complement CCTA allowing further quantification of plaque and other Coronary Artery Disease phenotypes. #artrya #cardiology #coronaryarterydisease # #artificialintelligence https://t.co/IjEpSHlkmW

[John Konstantopoulos @joconstant]

Photon counting CT is the future of coronary artery disease and atherosclerotic plaque assessment. Amazing imagery showing the clarity of this new imaging technology. #photoncounting #CT #atherosclerosis #plaque Siemens Healthineers GE Healthcare https://t.co/3yZ1H1sJrs

[John Konstantopoulos @joconstant]

This is a significant milestone for Artrya, enabling us to market into the United Kingdom and supply Salix Coronary Anatomy to 1250 NHS Trust Hospitals. This makes Salix one of very few companies providing plaque analysis within the UK. #nhs #hospitals #p…https://t.co/VcOtn1vFrN

[Artrya @Artrya1]

Artrya announced today it has received regulatory approval for its Salix Coronary Anatomy (SCA) product in Europe.

Managing Director and CEO John Barrington AM said this was an important moment for the company.

View full announcement: https://t.co/MJrdF0hT8g

[John Konstantopoulos @joconstant]

Huge achievement today for Artrya Ltd in receiving CE Mark regulatory approval. This enables a significant opportunity to provide Artrya's non-invasive solution Salix Coronary Anatomy in Europe and provide clinicians with a more comprehensive understandin…https://t.co/HOUERHex3p

[John Konstantopoulos @joconstant]

Great news with newly assigned reimbursement code and payment rate by CMS for the assessment, quantification, and characterisation of atherosclerotic plaque from CCTA. This is a major milestone and further support for CCTA as a fir…https://t.co/jflnf7uo3j https://t.co/iMQHLaB81J

[John Konstantopoulos @joconstant]

Fantastic achievement of winning the Best Abstract Award at @Heart_SCCT by @AIhdayhid @PerkinsComms and @Artrya1 #scct2022 #coronaryarterydisease #AI

[John Konstantopoulos @joconstant]

The latest CAD-RADS coronary CT guidelines are out.

“Even though coronary CTA can be a very useful test when performed on the right patient population, the test itself does not change outcomes. Rather, it is how clinicians act on…https://t.co/dJIprBJp8u https://t.co/C7VUVpgWnH

[John Konstantopoulos @joconstant]

At Artrya we are defining the way coronary artery disease is diagnosed and assessed. Thanks Cameron Ramsden for the mention. #coronaryarterydisease #heartdisease #artificialintelligence #westernaustralia https://t.co/oSFqpfH1OC

[John Konstantopoulos @joconstant]

Welcome Jack Lewin, MD! #heartdisease #coronaryarterydisease https://t.co/xVgoo7Sd2N

[John Konstantopoulos @joconstant]

https://t.co/gF5NjMwGHE

[John Konstantopoulos @joconstant]

Coronary Plaque Seen in Half of Asymptomatic Individuals on CTA
#coronaryarterydisease #coronaryplaque #zerocalcium #heartdisease https://t.co/mnPzOLLitJ

[John Konstantopoulos @joconstant]

#coronaryarterydisease #chestpain #ctfirst https://t.co/HngTsjmYCN

[John Konstantopoulos @joconstant]

Excited to share our clinical partnership with The Heart Center, Huntsville AL. This is a major step for Artrya Ltd in validating AI for heart disease diagnosis. #ai #coronaryarterydisease #clinicalresearch Michael Ridner https://t.co/MSsJVplPbH

[John Konstantopoulos @joconstant]

https://t.co/PJFq8rrPE8